TMCnet News
Research and Markets: Global Anaplastic Large Cell Lymphoma (ALCL) Pipeline Review 2015 - 8 Companies & 14 Drug ProfilesResearch and Markets (http://www.researchandmarkets.com/research/szjlcs/anaplastic_large) has announced the addition of the "Anaplastic Large Cell Lymphoma (ALCL) - Pipeline Review, H2 2015" report to their offering. This report provides comprehensive information on the therapeutic development for Anaplastic Large Cell Lymphoma (ALCL), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Anaplastic Large Cell Lymphoma (ALCL) and special featureson late-stage and discontinued projects. The report enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Companies Involved in Therapeutics Development
Drug Profiles
For more information visit http://www.researchandmarkets.com/research/szjlcs/anaplastic_large
View source version on businesswire.com: http://www.businesswire.com/news/home/20151005005730/en/ |